Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, Jotham W., Brooks, Paige R., Vetelino, Michael G., Wirtz, Michael C., Arnold, Eric P., Huang, Jianhua, Sands, Steven B., Davis, Thomas I., Lebel, Lorraine A., Fox, Carol B., Shrikhande, Alka, Heym, James H., Schaeffer, Eric, Rollema, Hans, Lu, Yi, Mansbach, Robert S., Chambers, Leslie K., Rovetti, Charles C., Schulz, David W., Tingley, F. David, O'Neill, Brian T.·2005·Journal of Medicinal Chemistry
DOI 10.1021/jm050069n

Cited by (960)

Items 901–960 of 960

  1. The Pharmacist's Role in Smoking Cessation
    Jeannette Y. Wick · 2008 · The Consultant Pharmacist
  2. Short Syntheses of 1-Substituted Dibenzothiophenes and 3-Substituted Naphthothiophenes
    Erin N. Welsh, Emily K. Burke, Katherine Roberston, Alexander W. H. Speed · 2019 · ChemRxiv
  3. Diagnosis of Abuse and Addiction
    Otto‐Michael Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, VICTOR M. HESSELBROCK, Samuel Pombo› · 2020 · Springer eBooks
  4. Rapid Access to Chiral and Tripodal Cavitands from β‐Pinene
    Xiuze Wang, Radoslav Z. Pavlović, Tyler J. Finnegan, Pratik Karmakar, Curtis E. Moore, Jovica D. Badjić · 2022 · Chemistry - A European Journal
  5. Agents for Treatment of Withdrawal and Dependency: Varenicline
    Christian C. Jacob, Thomas T. Polak · 2022 · Springer eBooks
  6. Function and pharmacology of neuronal nAChRs
    R. Thomas Boyd · 2023 · Elsevier eBooks
  7. EPIDEMIOLOGIA PALENIA TYTONIU I METODY EFEKTYWNIE WSPIERAJĄCE WALKĘ Z UZALEŻNIENIEM OD NIKOTYNY
    Wojciech Wahl, Dorota Jędrzejczyk-Okońska, Adam Fronczak · 2019 · Prospects in Pharmaceutical Sciences
  8. Eficácia do uso de marcadores genéticos na escolha do tratamento farmacológico do tabagismo com bupropiona e vareniclina e implicações na combinação das drogas: estudo randomizado, controlado
    Patrícia Viviane Gaya · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  9. Construction of Bridged Benzazepines via Photo‐Induced Dearomatization
    Ting‐Ting Song, Yong‐Kang Mei, Yan Liu, Xiaoyu Wang, Shiyu Guo, Ding‐Wei Ji, Boshun Wan, Weiming Yuan, Qing‐An Chen · 2023 · Angewandte Chemie
  10. Modulators of nicotine reward and reinforcement
    Brandon J. Henderson, Samuel Tetteh-Quarshie, Nathan A. Olszewski · 2024 · Advances in pharmacology
  11. Gestion périopératoire des cigarettes conventionnelles et électroniques. Actualisation 2023. Une revue narrative de la littérature
    Margaux Mestdag, Stéphanie Degey, Eric P. DEFLANDRE · 2024 · Revue des Maladies Respiratoires
  12. Retrospective evaluation of COVID-19 incidence during smoking cessation treatment with varenicline
    Elif Barış, Gökçen Ömeroğlu Şi̇mşek, Aylin Arıcı, Mukaddes Gümüştekin, Oğuz Kılınç, Metiner Tosun · 2024 · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
  13. Chapter 54. Treatment of Substance Use Disorders
    Brian J. Sherman, Karen J. Hartwell, Aimee L. McRae‐Clark, Alexandra Herron, Kathleen T. Brady · 2024 · American Psychiatric Association Publishing eBooks
  14. Roles of metabotropic signaling of nicotine receptors in the development and maintenance of nicotine reward through regulation of dopamine D 3 receptor expression
    Dooti Kundu, Srijan Acharya, Shujie Wang, Yongkai Cao, Hee Jin Kim, Jae Hoon Cheong, Kyeong‐Man Kim · 2024 · Journal of Neurochemistry
  15. Allosteric Control of Super-Agonism in a Ligand-Gated Ion Channel
    Franco Viscarra, Teresa Minguez, Isabel Bermúdez, Philip Charles Biggin · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Deciphering the Activation Mechanism and Internal Signaling Pathways of Dopamine Receptor D1 bound with Various Ligands via Molecular Simulations
    Xing-Yan Lai, Hao‐Jen Hsu, Chun‐Chun Chang · 2025 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  17. Chapter 6.2 Use of microdialysis in drug discovery and development: industry and regulatory perspectives
    Hans Rollema, Chandra S. Chaurasia · 2006 · Handbook of behavioral neuroscience
  18. A Pharmacological Update and Safety Analysis of Medications for Smoking Cessation: Which Ones to Use?
    Canan Akman, Feride Sinem Akgün, Betül Akbuğa Özel, Bilgen Özkaya, Göksu Afacan, Özgür Karcıoğlu · 2026 · Current Pharmaceutical Design
  19. Understanding Nicotine Addiction: Personalizing Therapy for Smoking Cessation
    Jacob Stein, Ruth Minkin, Manish A. Parikh, MAURICE RAFIAA, William H. Frishman, Stephen J. Peterson · 2026 · Cardiology in Review
  20. Cytisine—New Challenges of a Well-Known Drug in the Treatment of Nicotine Addiction
    Lidia Bieniasz, Karol Wróblewski, Angelika Kamizela, A. Szyszkowska, Waldemar Jarosław Grzegorzewski, Anna Czerniecka‐Kubicka · 2026 · Journal of Clinical Medicine
  21. Time-varying mediated effects of the nicotine patch on smoking before and after a quit attempt when it is added to varenicline and counseling
    Nayoung Kim, Timothy B. Baker, Donna L. Coffman, Megan E. Piper, James H. Stein, Danielle E. McCarthy · 2026 · Drug and Alcohol Dependence
  22. Prescribing Under Pressure: History and Legal Insights Into Boxed Warnings for Psychotropic Drugs
    Guest Columnists:, Robert Esterquest, William J. Newman · 2026 · Journal of Psychiatric Practice
  23. Comparison of clinical outcomes between different smoking cessation therapies in patients with chronic kidney disease
    Jing-Quan Zheng, Yi‐Chou Hou, Chien‐Lin Lu, Joshua Wang, Hsiu-Chien Yang, Tin Tin Sandar, Cai‐Mei Zheng, Kuo‐Cheng Lu · 2026 · Research Square
  24. Docking Analysis of Drugs Used in the Treatment of Alzheimer’s Disease, Using Cell Membrane Receptors and Enzymes of the Kynurenine Pathway: A Pilot Study
    Abdulla A.‐B. Badawy, Shazia Dawood, Felix I. L. Clanchy, Richard O. Williams, Trevor W. Stone · 2026 · International Journal of Molecular Sciences
  25. Functionalization of fused N ‐heterocyclic frameworks using organometallic reagents: Reactivity, selectivity, and biological application
    Jenu Navyatha, Selvam Vasanth, Palanisamy Sowntharya, Pitchamuthu Amaladass, Vasudevan Dhayalan · 2026 · Bulletin of the Korean Chemical Society
  26. Therapeutic potential of varenicline in neuropsychiatric disorders: insights into its molecular mechanisms
    Abdolkarim Talebi Taheri, Michael Aschner, Fatemeh Rahmati-Dehkordi, O. Tamtaji · 2026 · Molecular Biology Reports
  27. BindingDB Entry 50039254: A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists.
    BindingDB · 2013 · UC San Diego
  28. BindingDB Entry 50044857: Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selectivea4ß2-nAChR Ligands.
    BindingDB · 2016 · UC San Diego
  29. BindingDB Entry 50009582: New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3* Nicotinic Receptors.
    BindingDB · 2021 · UC San Diego
  30. BindingDB Entry 50034073: Docking studies of benzylidene anabaseine interactions witha7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of relateda7 selective ligands.
    BindingDB · 2012 · UC San Diego
  31. BindingDB Entry 50022743: Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds.
    BindingDB · 2026 · UC San Diego
  32. BindingDB Entry 50042577: Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selectivea4ß2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats.
    BindingDB · 2013 · UC San Diego
  33. BindingDB Entry 50044154: Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.
    BindingDB · 2015 · UC San Diego
  34. BindingDB Entry 50048256: Synthesis and biological evaluation of novel hybrids of highly potent and selectivea4ß2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
    BindingDB · 2018 · UC San Diego
  35. BindingDB Entry 50038345: Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
    BindingDB · 2012 · UC San Diego
  36. BindingDB Entry 50040506: Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.
    BindingDB · 2013 · UC San Diego
  37. BindingDB Entry 50028853: Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    BindingDB · 2010 · UC San Diego
  38. BindingDB Entry 5532: 7-Azaindole derivatives as potential partial nicotinic agonists.
    BindingDB · 2012 · UC San Diego
  39. BindingDB Entry 50043624: The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.
    BindingDB · 2014 · UC San Diego
  40. BindingDB Entry 50043748: Synthesis and activity of substituted heteroaromatics as positive allosteric modulators fora4ß2a5 nicotinic acetylcholine receptors.
    BindingDB · 2014 · UC San Diego
  41. BindingDB Entry 50037393: In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
    BindingDB · 2012 · UC San Diego
  42. BindingDB Entry 50041968: Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
    BindingDB · 2013 · UC San Diego
  43. BindingDB Entry 50040471: Identification of novela4ß2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.
    BindingDB · 2013 · UC San Diego
  44. BindingDB Entry 50037598: 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
    BindingDB · 2012 · UC San Diego
  45. BindingDB Entry 50031251: Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
    BindingDB · 2010 · UC San Diego
  46. BindingDB Entry 50004601: Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligands.
    BindingDB · 2020 · UC San Diego
  47. BindingDB Entry 50028566: Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2.
    BindingDB · 2010 · UC San Diego
  48. BindingDB Entry 50045100: Recent developments in novel antidepressants targetinga4ß2-nicotinic acetylcholine receptors.
    BindingDB · 2016 · UC San Diego
  49. BindingDB Entry 50043453: QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at thea4ß2 anda3ß4 nicotinic acetylcholine receptors (nAChRs).
    BindingDB · 2014 · UC San Diego
  50. BindingDB Entry 50042476: Ion channels as therapeutic targets: a drug discovery perspective.
    BindingDB · 2013 · UC San Diego
  51. BindingDB Entry 50011567: Pyridine alkaloids with activity in the central nervous system.
    BindingDB · 2022 · UC San Diego
  52. BindingDB Entry 50043556: TBA
    BindingDB · 2014 · UC San Diego
  53. BindingDB Entry 50005284: Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR).
    BindingDB · 2020 · UC San Diego
  54. BindingDB Entry 50043943: Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
    BindingDB · 2014 · UC San Diego
  55. BindingDB Entry 50007593: An insight into medicinal chemistry of anticancer quinoxalines.
    BindingDB · 2021 · UC San Diego
  56. BindingDB Entry 50014100: Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.
    BindingDB · 2022 · UC San Diego
  57. BindingDB Entry 50033481: Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.
    BindingDB · 2011 · UC San Diego
  58. Regulation and Function of Neuronal Nicotinic Acetylcholine Receptors in Lung Cancer: A Dissertation
    Ma. Reina Improgo · 2011 · eScholarship@UMassChan
  59. Regulation of Neuronal Nicotinic Receptor Expression by Novel Ligands and Mechanisms
    G. Patrick Hussmann · 2012 · DigitalGeorgetown (Georgetown University Library)
  60. Estratégias para a cessação do tabagismo : uma revisão das alternativas terapêuticas
    Marlise Lara Fagundes · 2010 · Lume (Universidade Federal do Rio Grande do Sul)